Feng FY - Search Results

1

Biomarkers of Outcome in Patients With Localized Prostate Cancer Treated With Radiotherapy.

Hall WA, Lawton CA, Jani AB, Pollack A, Feng FY. Hall WA, et al. Among authors: feng fy. Semin Radiat Oncol. 2017 Jan;27(1):11-20. doi: 10.1016/j.semradonc.2016.09.001. Epub 2016 Sep 16. Semin Radiat Oncol. 2017. PMID: 27986207 Review.

2

The percent of positive biopsy cores improves prediction of prostate cancer-specific death in patients treated with dose-escalated radiotherapy.

Qian Y, Feng FY, Halverson S, Blas K, Sandler HM, Hamstra DA. Qian Y, et al. Among authors: feng fy. Int J Radiat Oncol Biol Phys. 2011 Nov 1;81(3):e135-42. doi: 10.1016/j.ijrobp.2011.01.007. Epub 2011 Feb 23. Int J Radiat Oncol Biol Phys. 2011. PMID: 21345617

3

Continued benefit to androgen deprivation therapy for prostate cancer patients treated with dose-escalated radiation therapy across multiple definitions of high-risk disease.

Stenmark MH, Blas K, Halverson S, Sandler HM, Feng FY, Hamstra DA. Stenmark MH, et al. Among authors: feng fy. Int J Radiat Oncol Biol Phys. 2011 Nov 15;81(4):e335-44. doi: 10.1016/j.ijrobp.2011.04.037. Epub 2011 Jun 7. Int J Radiat Oncol Biol Phys. 2011. PMID: 21645976

4

Percentage of cancer volume in biopsy cores is prognostic for prostate cancer death and overall survival in patients treated with dose-escalated external beam radiotherapy.

Vance SM, Stenmark MH, Blas K, Halverson S, Hamstra DA, Feng FY. Vance SM, et al. Among authors: feng fy. Int J Radiat Oncol Biol Phys. 2012 Jul 1;83(3):940-6. doi: 10.1016/j.ijrobp.2011.09.005. Epub 2011 Nov 4. Int J Radiat Oncol Biol Phys. 2012. PMID: 22056069

5

The role of the maximum involvement of biopsy core in predicting outcome for patients treated with dose-escalated radiation therapy for prostate cancer.

Murgic J, Stenmark MH, Halverson S, Blas K, Feng FY, Hamstra DA. Murgic J, et al. Among authors: feng fy. Radiat Oncol. 2012 Aug 1;7:127. doi: 10.1186/1748-717X-7-127. Radiat Oncol. 2012. PMID: 22852797 Free PMC article.

6

Age and comorbid illness are associated with late rectal toxicity following dose-escalated radiation therapy for prostate cancer.

Hamstra DA, Stenmark MH, Ritter T, Litzenberg D, Jackson W, Johnson S, Albrecht-Unger L, Donaghy A, Phelps L, Blas K, Halverson S, Marsh R, Olson K, Feng FY. Hamstra DA, et al. Among authors: feng fy. Int J Radiat Oncol Biol Phys. 2013 Apr 1;85(5):1246-53. doi: 10.1016/j.ijrobp.2012.10.042. Epub 2012 Dec 19. Int J Radiat Oncol Biol Phys. 2013. PMID: 23265567

7

Retrospective evaluation reveals that long-term androgen deprivation therapy improves cause-specific and overall survival in the setting of dose-escalated radiation for high-risk prostate cancer.

Feng FY, Blas K, Olson K, Stenmark M, Sandler H, Hamstra DA. Feng FY, et al. Int J Radiat Oncol Biol Phys. 2013 May 1;86(1):64-71. doi: 10.1016/j.ijrobp.2012.11.024. Epub 2013 Feb 22. Int J Radiat Oncol Biol Phys. 2013. PMID: 23462420

8

Interval to biochemical failure predicts clinical outcomes in patients with high-risk prostate cancer treated by combined-modality radiation therapy.

Shilkrut M, McLaughlin PW, Merrick GS, Vainshtein JM, Feng FY, Hamstra DA. Shilkrut M, et al. Among authors: feng fy. Int J Radiat Oncol Biol Phys. 2013 Jul 15;86(4):721-8. doi: 10.1016/j.ijrobp.2013.03.028. Epub 2013 May 9. Int J Radiat Oncol Biol Phys. 2013. PMID: 23664325

9

Gleason pattern 5 is the strongest pathologic predictor of recurrence, metastasis, and prostate cancer-specific death in patients receiving salvage radiation therapy following radical prostatectomy.

Jackson W, Hamstra DA, Johnson S, Zhou J, Foster B, Foster C, Li D, Song Y, Palapattu GS, Kunju LP, Mehra R, Feng FY. Jackson W, et al. Among authors: feng fy. Cancer. 2013 Sep 15;119(18):3287-94. doi: 10.1002/cncr.28215. Epub 2013 Jul 2. Cancer. 2013. PMID: 23821578 Free article.

10

Salvage radiation therapy improves metastasis-free survival for clinically aggressive and indolent prostate cancer recurrences after radical prostatectomy.

Jackson WC, Johnson SB, Feng FY, Hamstra DA. Jackson WC, et al. Among authors: feng fy. Am J Clin Oncol. 2015 Aug;38(4):367-72. doi: 10.1097/COC.0b013e31829e17db. Am J Clin Oncol. 2015. PMID: 23822986

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

531 results

Search Page

Filters